GWS
TNDM icon

Glassman Wealth Services’s Tandem Diabetes Care TNDM Stock Holding History

Glassman Wealth Services’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-32
Closed -$665 – 2075
2023
Q3 		$665 Buy
32
+16
+100% +$439 ﹤0.01% 1670
2023
Q2 		$393 Sell
16
-44
-73% -$1.42K ﹤0.01% 1685
2023
Q1 		$2.44K Sell
60
-33
-35% -$1.37K ﹤0.01% 1186
2022
Q4 		$4.18K Buy
93
+91
+4,550% +$4.12K ﹤0.01% 1069
2022
Q3 		$0 Sell
2
-187
-99% -$10.3K ﹤0.01% 1982
2022
Q2 		$11K Buy
189
+173
+1,081% +$14.2K ﹤0.01% 792
2022
Q1 		$2K Buy
16
+8
+100% +$934 ﹤0.01% 1272
2021
Q4 		$1K Buy
8
+4
+100% +$540 ﹤0.01% 1513
2021
Q3 		$0 Buy
4
+2
+100% +$220 ﹤0.01% 1815
2021
Q2 		$0 Buy
+2
New +$178 ﹤0.01% 1652
2019
Q4 		– Sell
-3
Closed – – 1485
2019
Q3 		$0 Hold
3
– – ﹤0.01% 1369
2019
Q2 		$0 Buy
+3
New +$194 ﹤0.01% 1361

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Glassman Wealth Services's TNDM Position: Q4 2023 in Review

Glassman Wealth Services sold out of Tandem Diabetes Care (TNDM) in Q4 2023, closing a stake of 32 shares — an estimated $665 sold.

Glassman Wealth Services first reported a position in TNDM in Q2 2019 and held it in 12 quarters. The position peaked at $11K in Q2 2022. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2023.

  • Glassman Wealth Services reported no remaining Tandem Diabetes Care position as of Q4 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 32 Tandem Diabetes Care shares in Q4 2023, an estimated $665.
  • Glassman Wealth Services first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 12 quarters.
  • Glassman Wealth Services's Tandem Diabetes Care position peaked at $11K in Q2 2022.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2023.

Based on Glassman Wealth Services's 13F filing for Q4 2023, filed 12 Feb 2024.